0 168

Cited 0 times in

Impact of mutation status on efficacy outcomes in TOPAZ-1: A phase III study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in advanced biliary tract cancer (BTC)

DC Field Value Language
dc.date.accessioned2023-06-02T00:58:41Z-
dc.date.available2023-06-02T00:58:41Z-
dc.date.issued2022-11-
dc.identifier.issn0923-7534-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/194556-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherOxford University Press-
dc.relation.isPartOfANNALS OF ONCOLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleImpact of mutation status on efficacy outcomes in TOPAZ-1: A phase III study of durvalumab (D) or placebo (PBO) plus gemcitabine and cisplatin ( plus GC) in advanced biliary tract cancer (BTC)-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorJ.W. Valle-
dc.contributor.googleauthorS. Qin-
dc.contributor.googleauthorL. Antonuzzo-
dc.contributor.googleauthorD. Tougeron-
dc.contributor.googleauthorC-K. Lee-
dc.contributor.googleauthorB.J. Tan-
dc.contributor.googleauthorM. Ikeda-
dc.contributor.googleauthorV. Guthrie-
dc.contributor.googleauthorP. McCoon-
dc.contributor.googleauthorY.S. Lee-
dc.contributor.googleauthorN. Rokutanda-
dc.contributor.googleauthorM. Żotkiewicz-
dc.contributor.googleauthorG. Cohen-
dc.contributor.googleauthorD-Y. Oh-
dc.identifier.doi10.1016/j.annonc.2022.10.104-
dc.relation.journalcodeJ00171-
dc.identifier.eissn1569-8041-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0923753422042958-
dc.citation.volume33-
dc.citation.numberSuppl 9-
dc.citation.startPageS1457-
dc.identifier.bibliographicCitationANNALS OF ONCOLOGY, Vol.33(Suppl 9) : S1457, 2022-11-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.